ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Aug 18, 2025 | Sale | $25.18 | 22,000 | 554,024 | 40,130 | Aug 19, 2025, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 16, 2025 | Sale | $25.00 | 2,000 | 50,000 | 62,130 | May 19, 2025, 08:50 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 01, 2025 | Option/RSU Exercise | - | 6,815 | - | 66,271 | May 02, 2025, 07:59 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 02, 2025 | Sale | $14.60 | 3,498 | 51,071 | 62,773 | May 02, 2025, 07:59 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Apr 05, 2025 | Option/RSU Exercise | - | 5,275 | - | 62,164 | Apr 08, 2025, 07:40 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Apr 08, 2025 | Sale | $14.82 | 2,708 | 40,133 | 59,456 | Apr 08, 2025, 07:40 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 25, 2025 | Option/RSU Exercise | - | 6,178 | - | 60,060 | Mar 26, 2025, 08:06 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 26, 2025 | Sale | $17.05 | 3,171 | 54,066 | 56,889 | Mar 26, 2025, 08:06 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Feb 23, 2025 | Option/RSU Exercise | - | 1,353 | - | 54,655 | Feb 25, 2025, 06:46 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Feb 24, 2025 | Sale | $19.96 | 773 | 15,429 | 53,882 | Feb 25, 2025, 06:46 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Nov 17, 2024 | Option/RSU Exercise | - | 19,826 | - | 63,561 | Nov 19, 2024, 08:40 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Nov 19, 2024 | Sale | $16.81 | 10,259 | 172,454 | 53,302 | Nov 19, 2024, 08:40 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Aug 19, 2024 | Sale | $15.28 | 9,733 | 148,720 | 43,735 | Aug 20, 2024, 06:46 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Jun 08, 2024 | Option/RSU Exercise | - | 1,893 | - | 35,539 | Jun 11, 2024, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Jun 10, 2024 | Sale | $14.79 | 975 | 14,420 | 34,564 | Jun 11, 2024, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 01, 2024 | Option/RSU Exercise | - | 6,814 | - | 35,556 | May 03, 2024, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | May 02, 2024 | Sale | $16.94 | 3,503 | 59,341 | 32,053 | May 03, 2024, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Apr 05, 2024 | Option/RSU Exercise | - | 5,275 | - | 31,458 | Apr 09, 2024, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Apr 08, 2024 | Sale | $17.87 | 2,716 | 48,535 | 28,742 | Apr 09, 2024, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Mar 27, 2024 | Sale | $17.90 | 5,434 | 97,269 | 26,183 | Mar 27, 2024, 07:57 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Feb 23, 2024 | Option/RSU Exercise | - | 1,353 | - | 21,839 | Feb 27, 2024, 06:13 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | Feb 26, 2024 | Sale | $24.67 | 772 | 19,045 | 21,067 | Feb 27, 2024, 06:13 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Nov 17, 2023 | Option/RSU Exercise | - | 9,912 | - | 25,594 | Nov 21, 2023, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Nov 20, 2023 | Sale | $22.64 | 5,108 | 115,645 | 20,486 | Nov 21, 2023, 06:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Aug 21, 2023 | Sale | $29.00 | 10,000 | 289,970 | 15,682 | Aug 23, 2023, 07:31 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Jun 08, 2023 | Option/RSU Exercise | - | 1,893 | - | 23,798 | Jun 12, 2023, 08:48 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Jun 08, 2023 | Sale | $25.02 | 974 | 24,369 | 22,824 | Jun 12, 2023, 08:48 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | May 17, 2023 | Sale | $22.50 | 15,310 | 344,475 | 21,905 | May 19, 2023, 06:48 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | May 17, 2023 | Option/RSU Exercise | - | 29,738 | - | 37,215 | May 19, 2023, 06:48 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Apr 05, 2023 | Option/RSU Exercise | - | 5,275 | - | 9,393 | Apr 07, 2023, 08:37 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Apr 06, 2023 | Sale | $18.16 | 1,916 | 34,795 | 7,477 | Apr 07, 2023, 08:37 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Feb 23, 2023 | Option/RSU Exercise | - | 1,353 | - | 4,695 | Feb 27, 2023, 09:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Feb 24, 2023 | Sale | $18.78 | 577 | 10,836 | 4,118 | Feb 27, 2023, 09:00 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Jun 08, 2022 | Option/RSU Exercise | - | 1,893 | - | 3,995 | Jun 10, 2022, 08:51 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | EVP, Chief Financial Officer | Jun 09, 2022 | Sale | $17.91 | 653 | 11,695 | 3,342 | Jun 10, 2022, 08:51 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | Chief Financial Officer | Feb 23, 2022 | Option/RSU Exercise | - | 1,352 | - | 2,655 | Feb 25, 2022, 05:43 PM |
ACAD | | ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | Chief Financial Officer | Feb 23, 2022 | Sale | $23.80 | 553 | 13,161 | 2,102 | Feb 25, 2022, 05:43 PM |